Article
Immunity response against mild-to-moderate breakthrough COVID-19
2022-05-31
Abstract excerpt
<h4>ABSTRACT</h4> <h4>BACKGROUND</h4> The Omicron variant prevails the Delta variant after December 2021 in Thailand. Both variants of concern embody diverse epidemiological trends and immunogenicity, raising enormous public health concerns. We determined whether biological and clinical characteristics and immunogenicity of patients differ between Delta and Omicron during post-coronavirus disease 2019 (COVID-19) s...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 972749c0-8d52-50c8-a391-8aa22cb985db
- DOI
- 10.1101/2022.05.30.22275050
